Related Experiment Videos

[Tuberculin allergy in BCG-vaccinated children (author's transl)]

Monatsschrift Fur Kinderheilkunde
|September 1, 1975
PubMed

Insights

Bacille Calmette-Guérin (BCG) vaccination in newborns provides over 90% protection against tuberculosis in early childhood. This study confirms BCG

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Context:

  • Tuberculin allergy testing was performed on 431 BCG-vaccinated newborns, 400 unvaccinated children, and 30 children diagnosed with tuberculosis.
  • The study evaluated the frequency, duration, and intensity of tuberculin allergy in vaccinated versus unvaccinated children over time.

Purpose:

  • To assess the efficacy of BCG vaccination in preventing tuberculosis in neonates.
  • To compare the tuberculin reaction profiles between vaccinated, unvaccinated, and tuberculous children.
  • To determine the protective rate of BCG vaccination during the first five years of life.

Summary:

  • At 5 years old, 59% of BCG vaccinees showed positive tuberculin reactions (100 TE), with 36% still positive by age 7.
  • Only 4.7% of unvaccinated children aged 7-9 years were tuberculin-positive.
  • BCG vaccination demonstrated over 90% protection against tuberculosis in the first five years of life, preventing severe forms like miliary TB and TB meningitis in vaccinees.

Impact:

  • The findings support the recommendation for general BCG vaccination in newborns to reduce tuberculosis incidence and severity.
  • BCG vaccination significantly lowers the risk of critical tuberculosis complications in early childhood.
  • This study provides evidence for the long-term protective benefits of neonatal BCG immunization.

Related Concept Videos